Explore 3 Stock Ideas & Industry Insights Download Free Report

Stocks

Biomea Fusion Reports First Quarter 2025 Financial Results and Corporate Highlights

Company Announces Strategic Realignment to Focus on Core Programs and Extend Cash Runway Icovamenib progressing toward the next phase of clinical development in insulin deficient type 2 diabetes patients and patients that are currently uncontrolled on a GLP-1 based therapyBiomea's next generation oral GLP-1 …

EODHD | 05 May 2025

Context Therapeutics Announces Chief Medical Officer Transition

PHILADELPHIA, May 05, 2025 (GLOBE NEWSWIRE) -- Context Therapeutics Inc. (“Context” or “Company”) (Nasdaq: CNTX), a clinical-stage biopharmaceutical company advancing T cell engaging bispecific antibodies for solid tumors, today announced Dr. Karen Smith, MD, PhD, MBA, LLM as interim Chief Medical Officer (“CMO”). Dr. …

EODHD | 05 May 2025

The Vita Coco Company to Participate in the Goldman Sachs Global Staples Forum

NEW YORK, May 05, 2025 (GLOBE NEWSWIRE) -- The Vita Coco Company, Inc. (NASDAQ: COCO) (“Vita Coco” or the “Company”), a leading high-growth platform of better-for-you beverage brands, today announced that the Company will participate in the Goldman Sachs Global Staples Forum on May …

EODHD | 05 May 2025

CORCEPT THERAPEUTICS ANNOUNCES FIRST QUARTER FINANCIAL RESULTS AND PROVIDES CORPORATE UPDATE

Revenue of $157.2 million, compared to $146.8 million in first quarter 2024 Reiterated 2025 revenue guidance of $900 – $950 million Net income per common share (diluted) of $0.17, compared to $0.25 in first quarter 2024 Cash and investments of $570.8 million as of …

EODHD | 05 May 2025

Castle Biosciences to Acquire Previse

Expected to complement Castle’s current gastroenterology franchise Adds methylation technology developed at the Johns Hopkins University School of Medicine and additional technologies in development FRIENDSWOOD, Texas, May 05, 2025 (GLOBE NEWSWIRE) -- Castle Biosciences, Inc. (Nasdaq: CSTL), a company improving health through innovative tests …

EODHD | 05 May 2025

EverQuote Announces First Quarter 2025 Financial Results

First Quarter Revenue Growth of 83% Year-Over-Year to $166.6 millionFirst Quarter Variable Marketing Dollars Increase of 52% Year-Over-Year to $46.9 millionDelivers First Quarter Net Income of $8.0 million and Record Adjusted EBITDA of $22.5 million CAMBRIDGE, Mass., May 05, 2025 (GLOBE NEWSWIRE) -- EverQuote, …

EODHD | 05 May 2025

James River Announces Excess and Surplus Lines Leadership Retirement and Succession Plan

PEMBROKE, Bermuda, May 05, 2025 (GLOBE NEWSWIRE) -- James River Group Holdings, Ltd. ("James River" or the "Company") (NASDAQ: JRVR) announced today its plans for Todd Sutherland, current Senior Vice President, Management Liability within the Company’s Excess and Surplus Lines (“E&S”) segment, to succeed …

EODHD | 05 May 2025

James River Announces First Quarter 2025 Results

PEMBROKE, Bermuda, May 05, 2025 (GLOBE NEWSWIRE) -- James River Group Holdings, Ltd. ("James River" or the "Company") (NASDAQ: JRVR) reported net income from continuing operations available to common shareholders of $9.0 million ($0.18 per diluted share) and adjusted net operating income1 of $9.1 …

EODHD | 05 May 2025

MATSON, INC. ANNOUNCES FIRST QUARTER 2025 RESULTS

1Q25 EPS of $2.18 versus $1.04 in 1Q24 1Q25 Net Income of $72.3 million versus $36.1 million in 1Q24 1Q25 Consolidated Operating income of $82.1 million versus $36.9 million in 1Q24 1Q25 EBITDA of $131.7 million versus $82.8 million in 1Q24 Repurchased approximately 0.5 …

EODHD | 05 May 2025

Nasdaq Reports April 2025 Volumes

Nasdaq, Inc. NEW YORK, May 05, 2025 (GLOBE NEWSWIRE) -- Nasdaq (Nasdaq: NDAQ) today reported monthly volumes for April 2025 on its Investor Relations website. A data sheet showing this information can be found at: http://ir.nasdaq.com/financials/volume-statistics. About Nasdaq Nasdaq (Nasdaq: NDAQ) is a leading …

EODHD | 05 May 2025
Support

Hi! How can we help you today?

Loading…